Leucocyte Fingerprinting

Cheap, Early Detection of Covid-19 at high volumes.

Discovered by the MediChain Athena AI in April 2020 and winner of the Coronahack Coronavirus hackathon, Leucocyte Fingerprinting involves mesuring cell ratios taken using standard blood testing facilities. Highly sentitive and specific against 12 different viral infections most countries can already carry out hundreds of thosands to mellions of these tests and by entering them into our online API can get a result instantly which predicts the ocurance of COVID-19 long before serum or PCR tests. Published in the Journal of Infection in May 2020 and two patents pending.

• Testing using existing blood testing infrastructure
• No reagents or new staff needed

Close Project

Low Volume Home Test for Covid-19

Just a pin-prick of blood. Test on any Smartphone.

Our Low volume test uses leucocyte fingerprinting with a small, low cost clip on microscope and haemocytomer which fits any smartphone and allows analysis of a tiny drop of blood taken with a normal glucose testing lancet. Costs just a few $$ and each subsequent test cost just pennies and takes just minutes. Under development. Contact to pre-order.

• Date: Q2 2020
• Stage: Pre-launch
• Action: Contact Us

Close Project

Telemedicine App

Make sure you get the right data

Hypatia: An instant out of the box telemedicine solution for any smartphone or computer platform, for disease-free consultations at any distance (including internationally). Two Key Problems that Hypatia Addresses - both particularly important for Covid-19:

- Medical data analysis is needed to inform public policy and hospital processes for the best health and economic outcomes.

- Patients and doctors need to communicate quickly and conveniently, without travel and without spreading infections between them.

Video call platforms like Skype and Zoom are just web conferencing apps and are not specifically designed for medical consultations:

They do not contain workflow processing, so the doctor’s time (which is expensive) is wasted setting up or waiting for calls.

They do not gather or analyze patient data, e.g. indicative data needed to predict likely areas of Covid-19 outbreak for hospitals and government, so cannot inform public policy or hospital processes, so cannot help end the pandemic.

The Solution: The Hypatia app creates a professional workflow where the whole call process is initiated by a single patient click (not a complex link that has to be sent out).

A key factor now is that Hypatia gathers the indicative data needed to predict likely areas of Covid-19 outbreak for hospitals and government.

Introducing workflow means that costs are greatly reduced, as doctors’ time is far more expensive than receptionists’ time - it improves use of doctors’ time as patients can be routed through a receptionist/nurse to get patient details, reducing expensive doctor time.

Busy doctors are not kept waiting or made to site in the office setting up Zoom meetings or trying to handle incoming Skype calls while on a consultation. It is the difference between the doctor as an amateur on the internet and the doctor as part of an efficient healthcare system.

Trivial tasks are automatically apportioned to the receptionist or assistant. This is why western doctors can often handle workflows of 50 patients a day while doctors without workflow processing might only handle 10 with far greater exhaustion. The Skype method can be 300%-500% more expensive for the clinics or hospitals than Hypatia with far fewer patients treated.

Doctors and patients therefore connect at the touch of a button, with access and patient flow controlled by the clinic or hospital.

Much easier to use and more suitable than Skype or Zoom, and allows long range disease-free consultations at any distance (including internationally). No training needed (although we can provide) and can scale nationally immediately.

Servers and data can be kept fully confidential and within national boundaries.

• Date: Q4 2019
• Availability: Available
• Action: Order

Close Project

Coronahack Team

The winning team included:

Mark R. Baker, MediChain founder.
Abhirup Banerjee, Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford.
,Chris Barrett, Angel Investor.
Jalil El, TriMedx at Presence Saint Joseph Hospital.
Ivy Glavee, Fortune Dental Services.
Tom Jemmett, Strategy Unit – NHS Midlands and Lancashire Commissioning Support Unit.
Agnieszka Cecylia Kaczkowskai.
Joanne Kitson, School of Computer Science, Electrical and Electronic Engineering, and Engineering Maths, University of Bristol.
Louise S. Mackenzie, School of Pharmacy and Biomedical Sciences, University of Brighton.
Michail Mamalakis, School of Computer Science, University of Sheffield.
Surajit Ray, School of Mathematics and Statistics, University of Glasgow.
Shelley Taylor, Taylormade Business Consultants.
Bart Vorselaars, School of Mathematics and Physics, University of Lincoln.
Simonne Weeks, School of Pharmacy and Biomedical Sciences, University of Brighton.

Close

Project Name

Lorem ipsum dolor sit amet consectetur.

Use this area to describe your project. Lorem ipsum dolor sit amet, consectetur adipisicing elit. Est blanditiis dolorem culpa incidunt minus dignissimos deserunt repellat aperiam quasi sunt officia expedita beatae cupiditate, maiores repudiandae, nostrum, reiciendis facere nemo!

• Date: January 2017
• Client: Southwest
• Category: Website Design

Close Project

Project Name

Lorem ipsum dolor sit amet consectetur.

Use this area to describe your project. Lorem ipsum dolor sit amet, consectetur adipisicing elit. Est blanditiis dolorem culpa incidunt minus dignissimos deserunt repellat aperiam quasi sunt officia expedita beatae cupiditate, maiores repudiandae, nostrum, reiciendis facere nemo!

• Date: January 2017
• Client: Window
• Category: Photography

Close Project